Benjamin Rossi
Stock Analyst at JP Morgan
(2.50)
# 2,323
Out of 5,134 analysts
18
Total ratings
87.5%
Success rate
9.25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Benjamin Rossi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARDT Ardent Health | Maintains: Neutral | $12 → $11 | $9.78 | +12.47% | 4 | Jan 20, 2026 | |
| PACS PACS Group | Reinstates: Overweight | $44 | $41.01 | +7.29% | 1 | Dec 17, 2025 | |
| USPH U.S. Physical Therapy | Maintains: Overweight | $110 → $100 | $86.54 | +15.55% | 2 | Nov 24, 2025 | |
| SGRY Surgery Partners | Maintains: Neutral | $27 → $20 | $15.60 | +28.21% | 2 | Nov 24, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $200 → $230 | $234.25 | -1.81% | 3 | Nov 13, 2025 | |
| INNV InnovAge Holding | Assumes: Underweight | $5 | $8.48 | -41.04% | 1 | Sep 18, 2025 | |
| CON Concentra Group Holdings Parent | Assumes: Overweight | $31 | $23.66 | +31.02% | 1 | Sep 18, 2025 | |
| UHS Universal Health Services | Maintains: Neutral | $215 → $195 | $235.12 | -17.06% | 2 | Aug 4, 2025 | |
| HCA HCA Healthcare | Maintains: Neutral | $360 → $370 | $534.78 | -30.81% | 2 | Aug 4, 2025 |
Ardent Health
Jan 20, 2026
Maintains: Neutral
Price Target: $12 → $11
Current: $9.78
Upside: +12.47%
PACS Group
Dec 17, 2025
Reinstates: Overweight
Price Target: $44
Current: $41.01
Upside: +7.29%
U.S. Physical Therapy
Nov 24, 2025
Maintains: Overweight
Price Target: $110 → $100
Current: $86.54
Upside: +15.55%
Surgery Partners
Nov 24, 2025
Maintains: Neutral
Price Target: $27 → $20
Current: $15.60
Upside: +28.21%
Tenet Healthcare
Nov 13, 2025
Maintains: Overweight
Price Target: $200 → $230
Current: $234.25
Upside: -1.81%
InnovAge Holding
Sep 18, 2025
Assumes: Underweight
Price Target: $5
Current: $8.48
Upside: -41.04%
Concentra Group Holdings Parent
Sep 18, 2025
Assumes: Overweight
Price Target: $31
Current: $23.66
Upside: +31.02%
Universal Health Services
Aug 4, 2025
Maintains: Neutral
Price Target: $215 → $195
Current: $235.12
Upside: -17.06%
HCA Healthcare
Aug 4, 2025
Maintains: Neutral
Price Target: $360 → $370
Current: $534.78
Upside: -30.81%